(Q37688960)

22 August 2017

1 reference

title

Venous thromboembolism and cancer: a systematic review (English)

1 reference

22 August 2017

main subject

venous thromboembolism

1 reference

1 reference

Celso Arrais Rodrigues

1

1 reference

22 August 2017

Renata Ferrarotto

2

1 reference

22 August 2017

Roberto Kalil Filho

3

1 reference

22 August 2017

Yana A S Novis

4

1 reference

22 August 2017

Paulo M G Hoff

5

1 reference

22 August 2017

publication date

1 July 2010

1 reference

Journal of Thrombosis and Thrombolysis

22 August 2017

published in

1 reference

22 August 2017

volume

30

1 reference

22 August 2017

issue

1

1 reference

22 August 2017

page(s)

67-78

1 reference

Venous thromboembolism and cancer: a two-way clinical association

22 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11239-010-0441-0

Chemotherapy in small bowel adenocarcinoma: 10-year experience of the British Columbia Cancer Agency

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11239-010-0441-0

Management of venous thromboembolism: a systematic review for a practice guideline

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11239-010-0441-0

Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.

21 January 2018

1 reference

12 December 2020

Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study

1 reference

12 December 2020

An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study

1 reference

12 December 2020

Treatment of venous thromboembolism in cancer patients

1 reference

12 December 2020

A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project.

1 reference

12 December 2020

Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial

1 reference

12 December 2020

Subcutaneous Fondaparinux versus Intravenous Unfractionated Heparin in the Initial Treatment of Pulmonary Embolism

1 reference

12 December 2020

Incidence of symptomatic deep venous thrombosis with epoetin alfa or darbepoetin alfa treatment of anemia in patients with ovarian or primary peritoneal cancer

1 reference

12 December 2020

Tissue factor: then and now

1 reference

12 December 2020

Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis.

1 reference

12 December 2020

Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS).

1 reference

12 December 2020

Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy

1 reference

12 December 2020

Phase III clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma: a clinical trial coordinated by the Eastern Cooperative Oncology Group

1 reference

12 December 2020

A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer

1 reference

12 December 2020

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

12 December 2020

Tissue factor as an effector of angiogenesis and tumor progression in hematological malignancies

1 reference

12 December 2020

Venous thrombosis in cancer patients: insights from the FRONTLINE survey

1 reference

12 December 2020

Risk factors for venous thromboembolic events in cancer patients

1 reference

12 December 2020

Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

1 reference

12 December 2020

A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group

1 reference

12 December 2020

Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

1 reference

12 December 2020

Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study

1 reference

12 December 2020

Venous Thromboembolism Associated With Long-Term Use of Central Venous Catheters in Cancer Patients

1 reference

12 December 2020

The structural biology of expression and function of tissue factor

1 reference

12 December 2020

Venous thromboembolism and cancer: risks and outcomes

1 reference

12 December 2020

Incidence of venous thromboembolism in patients hospitalized with cancer

1 reference

12 December 2020

Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma

1 reference

12 December 2020

The effect of low molecular weight heparin on survival in patients with advanced malignancy

1 reference

12 December 2020

The role of aspirin in the prevention of thrombotic complications of thalidomide and anthracycline-based chemotherapy for multiple myeloma

1 reference

12 December 2020

Cancer and venous thromboembolism.

1 reference

12 December 2020

Incorrect use of thromboprophylaxis for venous thromboembolism in medical and surgical patients: results of a multicentric, observational and cross-sectional study in Brazil.

1 reference

12 December 2020

Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data

1 reference

12 December 2020

Trousseau's syndrome: multiple definitions and multiple mechanisms

1 reference

12 December 2020

Hematologic changes and thromboembolic complications in neoplastic disease and their relationship to metastasis

1 reference

12 December 2020

Venous thromboembolism and cancer: guidelines of the Italian Association of Medical Oncology (AIOM).

1 reference

12 December 2020

Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528,693 adults

1 reference

12 December 2020

Development and validation of a predictive model for chemotherapy-associated thrombosis

1 reference

12 December 2020

Management of venous thromboembolism in patients with advanced cancer: a systematic review and meta-analysis.

1 reference

12 December 2020

Excess risk of cancer in patients with primary venous thromboembolism: a national, population-based cohort study

1 reference

12 December 2020

Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study

1 reference

12 December 2020

High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS).

1 reference

12 December 2020

Prevalence of factor V Leiden, FII G20210A, FXIII Val34Leu and MTHFR C677T polymorphisms in cancer patients with and without venous thrombosis

1 reference

12 December 2020

Evaluation of perioperative fatal pulmonary embolism and death in cancer surgical patients: the MC-4 cancer substudy

1 reference

12 December 2020

The prevalence and associated variables of deep venous thrombosis in patients with advanced cancer

1 reference

12 December 2020

The Long-Term Clinical Course of Acute Deep Venous Thrombosis

1 reference

12 December 2020

Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients.

1 reference

12 December 2020

The incidence of venous thromboembolism among patients with primary lung cancer

1 reference

12 December 2020

Incidence of venous thromboembolism and its effect on survival among patients with common cancers

1 reference

12 December 2020

Guidelines on oral anticoagulation (warfarin): third edition--2005 update

1 reference

12 December 2020

A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients

1 reference

12 December 2020

Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer

1 reference

12 December 2020

Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer

1 reference

12 December 2020

Prognosis of Cancers Associated with Venous Thromboembolism

1 reference

12 December 2020

Alterations of hemostasis associated with malignancy: etiology, pathophysiology, diagnosis and management

1 reference

12 December 2020

Venous thromboembolic disease. Clinical practice guidelines in oncology

1 reference

12 December 2020

The effect of low-molecular-weight heparin on cancer survival. A systematic review and meta-analysis of randomized trials

1 reference

12 December 2020

The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism

1 reference

12 December 2020

Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab

1 reference

12 December 2020

A comparison of the safety and efficacy of oral anticoagulation for the treatment of venous thromboembolic disease in patients with or without malignancy.

1 reference

12 December 2020

Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial

1 reference

12 December 2020

Identifying cancer patients at risk for venous thromboembolism.

1 reference

12 December 2020

Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

1 reference

12 December 2020

Postoperative pulmonary embolism after hospital discharge. An underestimated risk

1 reference

12 December 2020

Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study

1 reference

12 December 2020

Redefining the target: chemotherapeutics as antiangiogenics

1 reference

12 December 2020

Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer

1 reference

12 December 2020

Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients

1 reference

12 December 2020

Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

12 December 2020

Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

12 December 2020

Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer

1 reference

12 December 2020

The risk of venous thromboembolic disease associated with adjuvant hormone therapy for breast carcinoma: a systematic review

1 reference

12 December 2020

Multicenter, randomized, double-blind, placebo-controlled study of thalidomide plus dexamethasone compared with dexamethasone as initial therapy for newly diagnosed multiple myeloma

1 reference

12 December 2020

Factor V Leiden, prothrombin 20210A and the risk of venous thrombosis among cancer patients

1 reference

12 December 2020

Efficacy of low- molecular- weight- heparin versus vitamin K antagonists for long term treatment of cancer-associated venous thromboembolism in adults: a systematic review of randomized controlled trials

1 reference

12 December 2020

Management of venous thromboembolism in cancer patients: ESMO clinical recommendations

1 reference

12 December 2020

The diagnosis and management of cardiovascular disease in cancer patients

1 reference

12 December 2020

American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.

1 reference

12 December 2020

Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer

1 reference

12 December 2020

Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)

1 reference

12 December 2020

The risk of a second cancer after hospitalisation for venous thromboembolism.

1 reference

12 December 2020

Treatment of venous thromboembolism in cancer patients

1 reference

12 December 2020

Venous thromboembolism in ovarian cancer

1 reference

12 December 2020

Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis.

1 reference

12 December 2020

Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients

1 reference

12 December 2020

Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study

1 reference

12 December 2020

Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival

1 reference

12 December 2020

The effect of very-low-dose warfarin on markers of hypercoagulation in metastatic breast cancer: results from a randomized trial.

1 reference

12 December 2020

Approaches to risk-stratifying cancer patients for venous thromboembolism.

1 reference

12 December 2020

Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study

1 reference

12 December 2020

Venous thromboembolism and cancer

1 reference

12 December 2020

Incidence of venous thromboembolism and the impact on survival in breast cancer patients

1 reference

12 December 2020

Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer

1 reference

12 December 2020

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

1 reference

12 December 2020

Venous thrombosis in patients with solid tumors: determination of frequency and characteristics

1 reference

12 December 2020

Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases. The Heparin Prophylaxis Study Group.

1 reference

12 December 2020

Malignancies, prothrombotic mutations, and the risk of venous thrombosis

1 reference

12 December 2020

Thromboembolism in hospitalized neutropenic cancer patients.

1 reference

12 December 2020

Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study

1 reference

12 December 2020

Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecular-weight heparins: a meta-analysis of randomised clinical trials

1 reference

12 December 2020

Risk factors associated with venous thromboembolic events in patients with malignancy

1 reference

12 December 2020

Thalidomide as initial therapy for early-stage myeloma

1 reference

12 December 2020

Thrombosis in multiple myeloma

1 reference

12 December 2020

High incidence of thromboembolism in patients with central nervous system lymphoma

1 reference

12 December 2020

Plasma coagulation markers in patients with solid tumors and venous thromboembolic disease receiving oral anticoagulation therapy

1 reference

12 December 2020

Thromboembolic events with lenalidomide-based therapy for multiple myeloma

1 reference

12 December 2020

Use of warfarin and risk of urogenital cancer: a population-based, nested case-control study

1 reference

12 December 2020

Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group.

1 reference

12 December 2020

A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer

1 reference

12 December 2020

10.1007/S11239-010-0441-0

Identifiers

DOI

1 reference

22 August 2017

1 reference